Profile
ACGN VRTX ALNY REGN ARGX SGEN
Company Name Aceragen, Inc. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $3.24M $100.41B $59.77B $58.74B $48.87B $43.15B
Employees 0.03K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO John C. Taylor Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
ACGN VRTX ALNY REGN ARGX SGEN
Quant Rating Score 3 1 4 3 3
Quant Rating Neutral Strong Sell Buy Neutral Neutral
Trading
ACGN VRTX ALNY REGN ARGX SGEN
Last Close $0.3849 $421.15 $450.68 $563.86 $798.94 $228.74
High 52 $0.38 $516.74 $482.13 $1016.53 $800 $228.74
Low 52 $0.38 $366.54 $224.58 $482.92 $520.52 $228.74
Price vs. 52 Week High 1.29 % -18.5 % -6.52 % -44.53 % -0.13 % 0 %
Price vs. 52 Week Low 1.29 % 14.9 % 100.68 % 16.76 % 53.49 % 0 %
Total Return
ACGN VRTX ALNY REGN ARGX SGEN
1 Month Return 0 % 6.22 % -6.52 % 1.32 % 4.1 % 0 %
3 Month Return 0 % -12.07 % 40.53 % 2.06 % 43.9 % 0 %
6 Month Return 0 % -12.68 % 85.28 % -2.14 % 41.7 % 0 %
9 Month Return 0 % 2.19 % 87.35 % -23.14 % 23.05 % 0 %
YTD Return 0 % 4.58 % 91.53 % -20.84 % 29.91 % 0 %
1 Year Return 0 % -10 % 66.36 % -44.29 % 53.49 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACGN VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) - 11.09 % -0.43 % 4.37 % 65.28 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Profitability
ACGN VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM - 86.11 % 83.64 % 81.98 % 65.82 % 79.1 %
Return on Assets TTM -23.1 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -113.18 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -34.91 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 78.71 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 106.69 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM - 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -4374.11 % 251.83 % -1.2 % 175.35 % 932.29 % -1043.73 %
Receivables Turnover TTM - 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM - 3.59 3.93 3.54 0.9 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.26 0.96
Fixed Asset Turnover TTM - 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM - 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -7.52 14.98 -0.12 45.13 5.67 -2.46
Free Cash Flow Per Share TTM -7.52 13.63 -0.4 36.58 5.58 -2.88
Cash Per Share TTM 369.9 % 2486.48 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM - 33.68 % -0.63 % 33.37 % 17.54 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 90.99 % 335.21 % 81.05 % 98.47 % 117.04 %
Cash Flow Coverage Ratios TTM -4374.11 % 251.83 % -1.2 % 175.35 % 932.29 % -1043.73 %
Price To Free Cash Flows Ratio TTM - 28.69 -1147.52 15.28 122.57 -81.26
Price To Operating Cash Flows Ratio TTM -0.06 26.14 -3805.41 12.49 140 -93.1
Price Cash Flow Ratio TTM -0.06 26.14 -3805.41 12.49 140 -93.1
Income Statement (TTM)
ACGN VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 100% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.01B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.02B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -7.17 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
ACGN VRTX ALNY REGN ARGX SGEN
Long Term Debt $0B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.06B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0.04B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.1B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
ACGN VRTX ALNY REGN ARGX SGEN
Net Income $-0.02B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.02B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 40.23
AARD Aardvark Therapeutics, Inc. Common Stock 17.13
ABCL AbCellera Biologics Inc. 6.17
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.54
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.88
ABPWW 0.0255
ABSI Absci Corporation 4.18
ABUS Arbutus Biopharma Corporation 4.18
ABVC ABVC BioPharma, Inc. 3.24
ABVX Abivax SA American Depositary Shares 86.51
ACAD ACADIA Pharmaceuticals Inc. 21.31
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.9287
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.45
ACIU AC Immune SA 3.52
ACLX Arcellx, Inc. 88.29
ETFs With Exposure to ACGN
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 331.81
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 147.27
VXF Vanguard Extended Market Index Fund 0.00002 212.75
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00002 161.41
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00002 161.42
VEMPX Vanguard Extended Market Index InstlPlus 0.00002 398.32
Unlock